ImageneBio, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
IMA Nasdaq 2830 www.inmagenebio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ImageneBio, Inc.

ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York - May 27th, 2026 2:30 pm
ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update - May 7th, 2026 2:05 pm
ImageneBio Announces $30 Million Private Placement - Apr 13th, 2026 5:00 am
Image Resources NL (ASX:IMA) Is About To Turn The Corner - Apr 1st, 2026 2:11 pm
Imax announces $28M opening weekend for Amazon/MGM/s ‘Project Hail Mary’ - Mar 24th, 2026 6:35 am
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Mar 17th, 2026 2:30 pm
ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update - Mar 10th, 2026 6:00 am
ImageneBio to Participate in Leerink Global Healthcare Conference - Feb 26th, 2026 6:00 am
ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer - Feb 10th, 2026 5:00 am
ImageneBio Insider Confidence Rewarded, Stock Hits US$76m Market Cap - Dec 31st, 2025 4:39 am
Here's Why We're Watching ImageneBio's (NASDAQ:IMA) Cash Burn Situation - Nov 15th, 2025 6:27 am
ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team - Nov 12th, 2025 5:15 am
ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences - Nov 6th, 2025 6:30 am
Wall Street Analysts Believe IMAGENEBIO INC (IMA) Could Rally 695.48%: Here's is How to Trade - Aug 5th, 2025 7:55 am
Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million - Jul 25th, 2025 9:00 am